REPLAGAL

Product Overview

About REPLAGAL

REPLAGAL is a prescription medication containing the active ingredient Agalsidase Alfa, used to treat Fabry disease, a genetic disorder caused by the buildup of a particular type of fat in the body's cells.

Key Benefits & Uses

• Treatment of Fabry disease to reduce the accumulation of globotriaosylceramide (Gb3 or GL-3) in various cells, including those in the kidneys, heart, and nervous system.
• Management of Fabry disease-related symptoms, such as pain, fatigue, and gastrointestinal issues.
• Reduction of the risk of Fabry disease-related complications, such as kidney disease and heart problems.

Active Ingredient & Action

Agalsidase Alfa, the active ingredient in REPLAGAL, is a recombinant human alpha-Gal A enzyme that works by breaking down the abnormal fat (Gb3 or GL-3) that accumulates in cells due to the deficiency of the enzyme alpha-Galactosidase A. This helps to reduce the symptoms and complications associated with Fabry disease.

Important Notes

REPLAGAL is available only by prescription and should be used under the guidance of a healthcare professional. Patients with Fabry disease should have regular monitoring of their kidney function, heart health, and other potential complications. It is essential to follow the recommended dosage and administration schedule to ensure the optimal efficacy and safety of REPLAGAL.